AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $17.30M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 13.59pm 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 32.0¢ | Day High | 35.0¢ | Day Low | 32.0¢ | |||
| Daily Volume | 128742 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 34.5¢ | 9013 | 0 | 39.5¢ | 526 | |
Directors & Senior Management
| Mr. Alexander Sanz | Co-Founder |
| Mr. Andres Vanegas | Co-Founder & Strategic Accounts Manager |
| Mr. Benjamin Brinquis | Head of Growth |
| Mr. Carlos Palacio | Non-Executive Director |
| Mr. Damian Eric Banks | Independent Non-Executive Director |
| Dr. Douglas Lingard | Independent Non-Executive Director |
| Mr. Douglas Ronald Flynn | Non-Executive Chairman |
| Dr. German Arango | Co-Founder, CEO, MD & Executive Director |
| Dr. Jorge H-Marin Munoz | Co-Founder & Chief Medical Officer |
| Mr. Juan David Fajardo | VP of Global Sales |
| Ms. Kamille Dietrich | Company Secretary |
| Mr. Orlando Joven | Chief Operating Officer |
Data source: ADVFN
